See also this year's filing and all EDGAR filings for this company.
PDF Report 0000875320_2023_VERTEX_PHARMACEUTICALS_INC_MA.pdf
Logs
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0000875320, VERTEX PHARMACEUTICALS INC MA
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 13,234,800,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 1,691,600,000 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 3,224,500,000 |
| 4 | LiabilitiesCurrent | 2,742,100,000 |
| 5 | LiabilitiesNoncurrent | 1,065,300,000 |
| 6 | remainder_Liabilities | 430,800,000 |
| 7 | CostOfGoodsAndServicesSold | 1,080,300,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 944,700,000 |
| 9 | ResearchAndDevelopmentExpense | 2,540,300,000 |
| 10 | remainder_Expenses | 968,400,000 |
| 11 | remainder_Revenues | 8,930,700,000 |
| 12 | remainder_NetIncome | -75,000,000 |
| 13 | remainder_ComprehensiveNetIncome | -15,100,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 18,150,900,000 |
| 1 | Liabilities | 4,238,200,000 |
| 2 | Expenses | 5,533,700,000 |
| 3 | Revenues | 8,930,700,000 |
| 4 | StockholdersEquity | 13,912,700,000 |
| 5 | NetIncome | 3,322,000,000 |
| 6 | ComprehensiveNetIncome | 3,314,450,000 |
| 7 | BaseVar | 18,471,800,000 |
| 8 | EconomicCapitalRatio | 2.43 |
Edgar->Model Mapping
Feature Distribution
Change over Time
